Prognostic implication of SYT–SSX fusion type and clinicopathological parameters for tumor‐related death, recurrence, and metastasis in synovial sarcoma
Authors:
- 20 May 2009
- journal article
- Published by Wiley in Cancer Science
- Vol. 100 (6) , 1018-1025
Abstract
The present study aimed to describe the distribution and features of the SYT–SSX fusion gene in Chinese patients with synovial sarcoma (SS), and to analyze the prognostic value of SYT–SSX fusion type and clinicopathological parameters for tumor‐related death, recurrence, and metastasis in SS. SYT–SSX1 and SYT–SSX2 fusion transcripts were tested by reverse transcription–polymerase chain reaction in 141 formalin‐fixed, paraffin‐embedded SS. The prognostic implication of SYT–SSX fusion type and clinicopathological parameters were analyzed by univariate and multivariate survival analyses. SYT–SSX1 and SYT–SSX2 were detected in 50 (34.5%) and 91 (64.5%) tumors, respectively. SYT–SSX1 (risk ratio [RR] = 2.032, P = 0.004), larger tumor size (RR = 1.859, P = 0.008), and aggressive Fédération Nationale des Centers de Lutte Contre le Cancer grade (RR = 2.094, P = 0.001) were adverse predictors for disease‐specific survival. However, SYT–SSX fusion type was not associated with local recurrence‐free survival (P = 0.216). Patients with larger tumors (RR = 2.071, P = 0.005) and those who received marginal excision (RR = 2.556, P = 0.005) had poor local recurrence‐free survival. Besides, SYT–SSX1 (RR = 1.859, P = 0.037), older age (RR = 1.799, P = 0.040), and aggressive International Union Against Cancer stage (RR = 3.690, P < 0.001) proved to be adverse prognostic factors for metastasis‐free survival. In conclusion, compared to SYT–SSX1, SYT–SSX2 was more frequent in Chinese patients with SS. Moreover, SYT–SSX1 was an adverse predictor for disease‐specific survival and metastasis‐free survival, but had no relation to local recurrence‐free survival. In addition, histological grade and tumor size were also important prognostic factors for SS. (Cancer Sci 2009; 100: 1018–1025)Keywords
This publication has 35 references indexed in Scilit:
- Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcomaEuropean Journal Of Cancer Prevention, 2006
- Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: Discussion on the role of adjuvant therapiesPediatric Blood & Cancer, 2005
- Synovial Sarcoma in Young PeopleJournal of Pediatric Hematology/Oncology, 2005
- Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?Cancer Detection Prevention, 2004
- Synovial sarcoma in children and adolescents: Thirty three years of experience with multimodal therapy*Medical and Pediatric Oncology, 2001
- Clinical impact of molecular and cytogenetic findings in synovial sarcomaGenes, Chromosomes and Cancer, 2001
- Association of SYT-SSX Fusion Types with Proliferative Activity and Prognosis in Synovial SarcomaLaboratory Investigation, 2000
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998
- Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location.American Journal of Roentgenology, 1995
- Synovial sarcoma outcome following conservation surgery and radiotherapyRadiotherapy and Oncology, 1994